COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 155: Articles 1541-1550  | Next

Effectiveness of digital health interventions against COVID-19 misinformation: a systematic realist review of intervention trials
Dickinson, R., Makowski, D., van Marwijk, H., Ford, E.
10.1101/2024.08.07.24311635 — Posted: 2024-08-08
The role of a structured community health worker network in achieving malaria elimination goals in the Dominican Republic: an impact evaluation amid COVID-19 disruptions
Michelen Strofer, N., Tejada Bueno, N., Santos Felix, M. Y., Cruz Raposo, J. L., Lana, J. T., Turbe, V., Cohen, J. M., Napier, H. G.
10.1101/2024.08.07.24311633 — Posted: 2024-08-08
Hydrogen Sulfide (H2S)-Producing Oral Bacteria May Protect Against COVID-19
Vaishnani, M., Modi, A., Chauhan, k., Parekh, B.
10.1101/2024.08.07.24311606 — Posted: 2024-08-08
Novel dPCR-Based Approach for SARS-CoV-2 Variant Detection and Monitoring in Wastewater: A Multi-State Comparison with Clinical Genotyping and GISAID Sequencing Data
Acer, P., Andersen, P., Barbero, R., Barksdale, S., Bellakbira, S., Bunde, D., Dunlap, R., Erickson, J., Goldfarb, D., Jones-Roe, T., Kilroy, M., Le, H., Lepene, B., Milich, E., Mohamed, A., Mosavi, S., Munns, D., Obermeyer, J., Patnaik, A., Pricer, G., Reven, M., Richardson, D., Ruhunusiri, C., Saswata, S., Saunders, L. P., Swahn, O., Vengurlekar, K., White, D., Lozach, J., Flores-Baffi, A. P., Easton, F., Dahlke, M., Fang, A., Cibin, D., Wesselman, T., Sablon, O., Wolfe, M., Liu, P., Hilton, S., Wang, Y., Moe, C. L., Kashwala, S., Camarato, E., Shrestha, S., Wied, R., Roguet, A., Janssen, K.
10.1101/2024.08.07.24311627 — Posted: 2024-08-08
PD-L1 mediated T cell inhibition by regulatory plasma cells induced after sepsis and COVID-19
Gossez, M., Vigneron, C., Vandermoeten, A., Lepage, M., Courcol, L., Coudereau, R., Paidassi, H., Jallades, L., Lopez, J., Kandara, K., Ortillon, M., Mommert, M., Fabri, A., Peronnet, E., Grosjean, C., Buisson, M., Lukaszewicz, A.-C., Rimmele, T., Argaud, L., Cour, M., Py, B. F., Thaunat, O., Defrance, T., monneret, g., VENET, F.
10.1101/2024.08.08.24311630 — Posted: 2024-08-08
An empirical cross-sectional analysis of the corrections in the New York Times COVID-19 coverage
Haslam, A., Harshman, Q., Prasad, V.
10.1101/2024.08.02.24311424 — Posted: 2024-08-08
Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults With Underlying Medical Conditions in the United States
Kopel, H., Nguyen, V. H., Bogdanov, A. N., Winer, I., Boileau, C., Ducruet, T., Zeng, N., Winer-Jones, J. P., Esposito, D. B., Bausch-Jurken, M., Beck, E., Bonafede, M., Mansi, J. A.
10.1101/2024.08.06.24311559 — Posted: 2024-08-07
Replicating a COVID-19 study in a national England database to assess the generalisability of research with regional electronic health record data
Williams, R., Jenkins, D., Bolton, T., Heald, A., Mizani, M. A., Sperrin, M., Peek, N., CVD-COVID-UK/COVID-IMPACT Consortium
10.1101/2024.08.06.24311538 — Posted: 2024-08-06
Defining short linear motif binding determinants by phage-based multiplexed deep mutational scanning
Benz, C., Maasen, L., Simonetti, L., Mihalic, F., Lindqvist, R., Tsitsa, I., Jemth, P., Overby, A. K., Davey, N. E., Ivarsson, Y.
10.1101/2024.08.06.606761 — Posted: 2024-08-06
Selective epigenetic regulation of IFN-γ signature genes by JAK inhibitor in inflammatory diseases
Kwon, G., Park, Y., Kang, K., Kang, K.
10.1101/2024.08.05.606293 — Posted: 2024-08-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).